GcMAF

Titlesort descending Average Rating
61 year old woman, Breast cancer with lymph, and lung metastasis 90.00%
63 year old woman with stage III malignant melanoma 100.00%
66 year man. Cholangiocarcinoma 80.00%
71 year old woman, Pancraetic cancer with liver and lung metastasis. 90.00%
71 year old woman. Breast cancer with bone metastasis 90.00%
82 year old woman. Breast cancer with lymph and bone metastasis. 80.00%
A new methodology of viewing extra-axial fluid and cortical abnormalities in children with autism via transcranial ultrasonography
Alert because of Scientific Fraud: Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF). 55.00%
Case Report: A Breast Cancer Patient Treated with GcMAF, Sonodynamic Therapy and Hormone Therapy 90.00%
CLINICAL EXPERIENCE OF CANCER IMMUNOTHERAPY INTEGRATED WITH OLEIC ACID COMPLEXED WITH DE-GLYCOSYLATED VITAMIN D BINDING PROTEIN 100.00%
Clinical experience of integrative cancer immunotherapy with GcMAF. 80.00%
EFFECTS OF GC-MACROPHAGE ACTIVATING FACTOR IN HUMAN NEURONS; IMPLICATIONS FOR TREATMENT OF CHRONIC FATIGUE SYNDROME 90.00%
GcMAF studies presented at IACFS/ME meetings in Ottawa 90.00%
GcMAF-The cancer revolution from Japan 87.50%
Holistic Cancer Treatment and Psychotherapy inspired by Dr Fred B Levenson 100.00%
Holistisk Cancer Behandling och Cancer Psykoterapi Inspirerad av Dr. Fred B. Levenson 100.00%
Immunotherapy with GcMAF revisited - A critical overview of the research of Nobuto Yamamoto 80.00%
Oleic Acid, deglycosylated vitamin D-binding protein, nitric oxide: a molecular triad made lethal to cancer. 100.00%
Probiotic yogurt consumption is associated with an increase of CD4 count among people living with HIV/AIDS.hiv 80.00%
Removed because of suspicion of scientific fraud: Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF. 10.00%
Removed from Pubmed because of suspicion of scientific fraud: Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF). 55.00%
Removed from Pubmed because of suspiion of scientific fraud: Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF. 75.00%
The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages 100.00%
Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice. 90.00%
Vitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prosta 90.00%
Vitamin D Binding Protein-Macrophage Activating Factor Inhibits HCC in SCID Mice. 80.00%